Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D009364:Neoplasm Recurrence, Local; D011246:Pregnadienetriols / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D013311:Streptozocin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011246:Pregnadienetriols; D011344:Procarbazine; D004958:Estradiol; D013311:Streptozocin; D004054:Diethylstilbestrol; D003606:Dacarbazine; D003520:Cyclophosphamide; D005472:Fluorouracil; D006918:Hydroxyurea